Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day
Business Wire•07/10/2026•18:33 ET
15
Key Highlights
- ➤FY2031 targets high-single-digit to low-double-digit revenue growth
- ➤FY2031 adjusted EBITDA margin target reaches 30%
- ➤R&D investment to increase approximately 50% in FY2027
- ➤New product innovation expected to add $100 million revenue by FY2031
- ➤Adjusted gross margin targeted in high-50% range by FY2031
Expert Statements
Mike Nassif, President and Chief Executive Officer of Neogen
“Neogen has reached an inflection point”
Mike Nassif, President and Chief Executive Officer of Neogen
“We have stabilized the business, restored execution discipline, and are now focused on what we intend to do next – expanding our category leadership by driving core growth and pursuing opportunities for innovation, and delivering the financial performance that reflects the value we provide to our customers and to global food safety. Today we are presenting a plan for how we get there, and the evidence that we are already executing against it.”
Mike Nassif, President and Chief Executive Officer of Neogen
“Neogen combines the focused expertise of a food safety specialist with the global scale, broad portfolio, manufacturing capabilities, and technical expertise that Neogen brings to the market”
Mike Nassif, President and Chief Executive Officer of Neogen
“We believe the combination of these strengths with our deep customer relationships around the world is a unique competitive advantage and positions us to drive innovation, help solve increasingly complex food safety challenges, and create long-term value for shareholders.”
Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day
Company presented three pillars of value creation fueling its category leadership: commercial prowess, high-impact innovation and operational excellence
Get started
Create a free account to read the full story.